secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-11-22T23:59:59+00:00
Accession:  0001477932-23-008752
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health Q3 2023: Revenue $12.8M (+7% YoY), net loss $3.35M, Adj. EBITDA -$1.1M
--------------------------------------------------------------------------------

- Revenue $12.8M (+7% YoY); gross margin declined to 9.5% from 14.9% due to logistics mix.
- Net loss $3.35M vs $1.97M in Q3 2022; Adjusted EBITDA -$1.1M vs +$0.5M.
- SG&A doubled to $4.0M on R&D, acquisition integration, stock-based comp, and provisions.
- Total assets record $71.5M; stockholders' equity $44.2M ($3.4/share); debt reduced.
- Reiterated 2026 guidance: >$180M revenue, >$20M EBITDA; plans to spin off R&D division.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223008752/0001477932-23-008752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223008752/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-008752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer